Compounds > viloxazine
Page last updated: 2024-08-16

viloxazine and paroxetine

viloxazine has been researched along with paroxetine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlier, PR; Lo, MM; Lo, PC; Reynolds, IJ; Richelson, E; Sharma, TA; Tatsumi, M1
Lombardo, F; Obach, RS; Waters, NJ1
Smith, DF1
Broyer, M; Chamba, G; d'Amato, T; Dalery, J; Ghaemmaghami, C; Lestra, C; Perret-Liaudet, A; Renaud, B1
Antonietti, M; Denis, P; Ducrotte, P; Lalaude, O; Leroi, AM; Menard, JF; Touchais, JY1

Other Studies

5 other study(ies) available for viloxazine and paroxetine

ArticleYear
Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
    Bioorganic & medicinal chemistry letters, 1998, Mar-03, Volume: 8, Issue:5

    Topics: Amino Alcohols; Animals; Antidepressive Agents; Dopamine; Humans; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Serotonin; Species Specificity

1998
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
    Neuroscience and biobehavioral reviews, 1986,Spring, Volume: 10, Issue:1

    Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine

1986
Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome.
    Biological psychiatry, 1998, Aug-15, Volume: 44, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Benzamides; Biomarkers; Biopterins; Blood Platelets; Depressive Disorder; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Treatment Outcome; Viloxazine

1998
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants.
    Neurogastroenterology and motility, 2000, Volume: 12, Issue:2

    Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cathartics; Cholinergic Antagonists; Clomipramine; Colon; Colonoscopy; Constipation; Depressive Disorder; Eating; Fecal Impaction; Female; Gastrointestinal Motility; Humans; Male; Manometry; Maprotiline; Middle Aged; Mood Disorders; Muscle Contraction; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thiazepines; Viloxazine

2000